Technology | March 10, 2010

Statin-Based Drug Lowers Bad Cholesterol


An FDA-approved, cholesterol-lowering medication has been proven to significantly reduce the risk of heart attack, stroke, certain kinds of heart surgeries and chest pain.

Over 29 million people in the United States have been prescribed Lipitor, manufactured by Pfizer. It is one of the most widely studied medicines in the world — with more than 17 years of research, and over 400 ongoing or completed clinical studies encompassing over 80,000 patients.

In clinical studies, Lipitor lowered bad cholesterol significantly more than generic Zocor (simvastatin). Lipitor is a statin that lower cholesterol in your body by blocking an enzyme in the liver. Bodies uses this enzyme to make cholesterol. When less cholesterol is made, the liver uses more of it from the blood, which results in lower levels of cholesterol in the blood.

Along with diet and exercise, Lipitor is proven to:

• Lower LDL ("bad" cholesterol) by 39 to 60 percent
• Lower triglycerides (a type of fat found in the blood) by 19 to 37 percent
• Raise HDL ("good" cholesterol) by 5 percent to 9 percent


Related Content

News | Pharmaceuticals

February 16, 2024 — AMO Pharma Limited, a privately held clinical-stage specialty biopharmaceutical company focusing on ...

Home February 16, 2024
Home
News | Pharmaceuticals

January 25, 2024 — Agepha Pharma, a leading multinational pharmaceutical company with the first FDA-approved anti ...

Home January 25, 2024
Home
News | Pharmaceuticals

November 21, 2023 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

Home November 21, 2023
Home
Feature | Pharmaceuticals | By Christine Book

In a new 3-part video series on hypertrophic cardiomyopathy with Christine E. Seidman, MD, FACC, FAHA, Managing Editor ...

Home October 25, 2023
Home
Videos | Pharmaceuticals

In this third and final segment in DAIC’s “One on One” series with Dr. Christine Seidman, learn what’s on the horizon at ...

Home September 26, 2023
Home
Videos | Pharmaceuticals

In Part 2 of DAIC’s 3-part “One on One” series with Dr. Christine Seidman, a discussion on the discovery of gene-based ...

Home September 11, 2023
Home
Videos | Pharmaceuticals

A 3-part video series with Christine E. Seidman, MD, FACC, FAHA In the first of this 3-part “One on One” series, Dr ...

Home August 28, 2023
Home
News | Pharmaceuticals

August 1, 2023 —LEXEO Therapeutics, a clinical-stage gene therapy company advancing adeno-associated virus (AAV)-based ...

Home August 01, 2023
Home
News | Pharmaceuticals

July 10, 2023 — Novartis announced that the US Food and Drug Administration (FDA) has approved a label update for Leqvio ...

Home July 10, 2023
Home
Subscribe Now